2014		2015		2016		Rate(Cases per 100,000 per quarter)		Quarterly Rate Comparison
Disease	Q2 No.	YTD No.	Q2 No.	YTD No.	Q2 No.	YTD No.	Qtr2 (2011-2015 aggregated)	Qtr2 (2016)	Significant change bet. current & past 5-year?~~
VACCINE PREVENTABLE
DIPHTHERIA	0	0	0	0	0	0	0.00	0.00
HAEMOPHILUS INFLUENZA (INVASIVE)	.	6	7	12	8	15	0.23	0.38
HEPATITIS A	.	.	.	6	5	7	0.16	0.24
HEPATITIS B (ACUTE)	8	12	5	7	6	8	0.25	0.28
INFLUENZA**	118	502	63	446	78	503	4.05	3.69
MEASLES	0	0	0	9	0	0	0.00	0.00
MUMPS	.	.	0	0	0	0	0.01	0.00
PERTUSSIS	24	40	47	68	9	20	1.39	0.43	X
POLIOMYELITIS	0	0	0	0	0	0	0.00	0.00
RUBELLA	0	0	0	0	0	0	0.00	0.00
TETANUS	0	0	0	0	0	0	0.00	0.00
SEXUALLY TRANSMITTED
CHLAMYDIA	2598	5126	2381	4866	2566	5210	114.54	121.27	X
GONORRHEA	675	1241	654	1359	834	1587	26.64	39.42	X
HIV	93	147	88	153	85	169	3.49	4.02
SYPHILIS (EARLY LATENT)	72	143	82	175	116	254	2.80	5.48	X
SYPHILIS (PRIMARY & SECONDARY)	74	133	88	138	84	165	2.53	3.97	X
Stage 3 HIV (AIDS)	69	115	53	85	51	95	2.63	2.41
ENTERICS
AMEBIASIS	0	0	.	.	.	.	0.12	0.09
BOTULISM-INTESTINAL (INFANT)	0	0	0	0	0	0	0.00	0.00
CAMPYLOBACTERIOSIS	19	45	29	48	27	53	1.28	1.28
CHOLERA	0	0	0	0	0	0	0.00	0.00
CRYPTOSPORIDIOSIS	.	.	0	.	0	0	0.04	0.00
GIARDIA	12	18	11	19	14	23	0.58	0.66
ROTAVIRUS	35	42	26	63	21	24	1.57	0.99
SALMONELLOSIS	27	43	49	73	42	67	4.09	1.99	X
SHIGA-TOXIN PRODUCING E. COLI#	.	8	.	12	16	26	0.45	0.76
SHIGELLOSIS	.	9	.	9	8	19	0.27	0.38
TYPHOID FEVER	0	.	.	.	.	.	0.02	0.05
VIBRIO (NON-CHOLERA)	0	.	0	0	0	0	0.02	0.00
YERSINIOSIS	0	.	0	0	0	0	0.02	0.00
OTHER
ANTHRAX	0	0	0	0	0	0	0.00	0.00
BOTULISM INTOXICATION	0	0	0	0	0	0	0.00	0.00
BRUCELLOSIS	0	0	0	0	0	.	0.00	0.00
COCCIDIOIDOMYCOSIS	18	37	23	39	18	35	1.16	0.85
DENGUE FEVER	.	.	0	0	0	.	0.01	0.00
ENCEPHALITIS	0	0	0	.	0	0	0.01	0.00
HANTAVIRUS	0	0	0	0	0	0	0.00	0.00
HEMOLYTIC UREMIC SYNDROME (HUS)	.	.	0	0	0	0	0.01	0.00
HEPATITIS C (ACUTE)	.	.	.	6	8	11	0.08	0.38	X
HEPATITIS D	0	0	0	0	0	0	0.00	0.00
INVASIVE GROUP A STREP.##	0	0	0	0	0	0	0.00	0.00
LEGIONELLOSIS	5	6	6	14	.	7	0.20	0.19
LEPROSY (HANSEN’S DISEASE)	.	.	0	0	0	0	0.01	0.00
LEPTOSPIROSIS	0	0	0	0	0	0	0.00	0.00
LISTERIOSIS	.	.	.	.	0	0	0.05	0.00	X
LYME DISEASE	.	.	.	.	.	.	0.10	0.19
MALARIA	.	.	0	0	.	.	0.04	0.05
MENINGITIS, ASEPTIC/VIRAL	9	19	11	19	.	6	0.40	0.09
MENINGITIS, BACTERIAL	.	6	8	12	11	23	0.14	0.52	X
MENINGOCOCCAL DISEASE	0	.	0	0	0	.	0.00	0.00
PLAGUE	0	0	0	0	0	0	0.00	0.00
PSITTACOSIS	0	0	0	0	0	.	0.00	0.00
Q FEVER	0	0	.	.	0	0	0.01	0.00
RABIES (HUMAN)	0	0	0	0	0	0	0.00	0.00
RELAPSING FEVER	0	0	0	0	0	0	0.00	0.00
ROCKY MOUNTAIN SPOTTED FEVER	0	0	0	0	.	.	0.00	0.05
RSV (RESPIRATORY SYNCYTIAL VIRUS)	93	595	53	1093	34	289	4.00	1.61	X
STREPTOCOCCUS PNEUMONIAE, IPD###	19	49	23	65	26	89	0.74	1.23
TOXIC SHOCK SYN	0	0	0	0	0	0	0.00	0.00
TOXIC SHOCK SYN (STREPTOCOCCAL)	.	8	.	6	5	11	0.10	0.24
TUBERCULOSIS	24	36	32	47	14	17	1.23	0.66
TULAREMIA	0	0	0	0	0	0	0.00	0.00
UNUSUAL ILLNESS	0	0	0	0	0	0	0.01	0.00
WEST NILE VIRUS (ENCEPHALITIS)	0	0	0	0	0	0	0.04	0.00
WEST NILE VIRUS (FEVER)	0	0	0	0	0	0	0.01	0.00

*Due to software transition STD data since 2014 are not comparable with those in previous years. Rate denominators are interpolated population estimates/projections using demographic data under ongoing revisions by the state demographer. Use of onset date in data aggregation for cases other than STD or TB (since Jan-2013) causes changes in cases reported here from previously released reports. Numbers are provisional including confirmed, probable and suspect (since Feb-08) cases. HIV/AIDS/TB case counts provided by Office of Disease Surveillance. Data suppression denoted by ‘.’ applies if number of cases <5. Quarterly disease total (excluding STD and TB cases)=351(reported total=4101). Quarterly congenital syphilis cases (suppression applied) for 2014-2016 were 0,.,.(YTD totals of .,.,.) respectively.

**Reporting of novel type A influenza (reclassified as INFLU OUTBRK per CDC recommendations as of Jan-11) started in May-09.

#E. COLI O157:H7 instead of STEC was reported prior to 2006.

##Reported since Mar-07.

###S. pneumo invasive diseases (reported since Sep-05) previouly reported under separate categories grouped together as of Jan-11 per CDC recommendations.

~~Confidence intervals (not shown) for the quarterly disease incidence rates provided a basis for an informal statistical test to determine if the current quarterly rates changed significantly from those of the previous 5 years aggregated. Text in green where rates decreased and in red where rates increased. Statistically significant changes indicated by ‘X’ (rate comparisons made if 5+ cases reported in the current quarter of this year or previous 5 years aggregated).